Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Behrooz Hakimian"'
Autor:
Jonathan N. Le, Jordan O. Gasho, Olivia Peony, Asneh Singh, Katrina D. Silos, Sungjin Kim, Anthony T. Nguyen, Mitchell Kamrava, Amin Mirhadi, Behrooz Hakimian, Karen L. Reckamp, Kamya Sankar, Raymond H. Mak, Andriana P. Nikolova, Katelyn M. Atkins
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely
Externí odkaz:
https://doaj.org/article/5efc26f8cd4d40a6bdf3a4a3c7449ce6
Autor:
Allan Lipton, Matthew R. Smith, Robert J. Amato, Behrooz Hakimian, Robert G. Uzzo, G. David Roodman, Georgiana K. Ellis
Publikováno v:
Journal of the National Comprehensive Cancer Network. 7:S-1
Cancer and its treatment can compromise bone health, leading to fracture, pain, loss of mobility, and hypercalcemia of malignancy. Bone metastasis occurs frequently in advanced prostate and breast cancers, and bony manifestations are commonplace in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7e00fbc51a6b2ed0c08a817c94505bb
https://doi.org/10.6004/jnccn.2009.0080
https://doi.org/10.6004/jnccn.2009.0080
Autor:
Howard Rosner, Ajay Ananda, Christopher Zarembinski, Steven B. Graff-Radford, Behrooz Hakimian
Publikováno v:
Neurosurgery. 65:416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75c7e93b04174f47a617bbf25d8c1e99
https://doi.org/10.1227/01.neu.0000358718.72315.6f
https://doi.org/10.1227/01.neu.0000358718.72315.6f